From Spectrascience's Facebook page: NEWS BREAK
Post# of 1023
Posted On: 03/23/2016 9:19:49 PM
From Spectrascience's Facebook page:
NEWS BREAK - Biusness Standard
TRIBUNE StandardTrib.com
"SPECTRASCIENCE NEW (OTCMKTS:SCIE) Sellers Increased By 139.19% Their ShortsDavid Hannula | March 21, 2016
The stock of SPECTRASCIENCE NEW (OTCMKTS:SCIE) registered an increase of 139.19% in short interest. SCIE’s total short interest was 35,400 shares in March as published by FINRA. Its up 139.19% from 14,800 shares, reported previously. The stock increased 31.91% or $0.0015 on March 18, hitting $0.0062. About 9.98M shares traded hands. SpectraScience Inc (OTCMKTS:SCIE) has risen 6.00% since February 20, 2016 and is uptrending. It has outperformed by 7.62% the S&P500.
SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System . The company has a market cap of $1.62 million. The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. It currently has negative earnings. It has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy.
http://www.standardtrib.com/spectrascience-ne...horts.html
NEWS BREAK - Biusness Standard
TRIBUNE StandardTrib.com
"SPECTRASCIENCE NEW (OTCMKTS:SCIE) Sellers Increased By 139.19% Their ShortsDavid Hannula | March 21, 2016
The stock of SPECTRASCIENCE NEW (OTCMKTS:SCIE) registered an increase of 139.19% in short interest. SCIE’s total short interest was 35,400 shares in March as published by FINRA. Its up 139.19% from 14,800 shares, reported previously. The stock increased 31.91% or $0.0015 on March 18, hitting $0.0062. About 9.98M shares traded hands. SpectraScience Inc (OTCMKTS:SCIE) has risen 6.00% since February 20, 2016 and is uptrending. It has outperformed by 7.62% the S&P500.
SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System . The company has a market cap of $1.62 million. The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. It currently has negative earnings. It has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy.
http://www.standardtrib.com/spectrascience-ne...horts.html
(0)
(0)